Download PDF
Semin Liver Dis 2000; 20(4): 425-436
DOI: 10.1055/s-2000-13154
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Liver Transplantation for Hepatic and Biliary Malignancy

William J. Wall
  • Department of Surgery, University of Western Ontario, and Multi-Organ Transplant Program, London Health Sciences Centre, London, Ontario, Canada
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

The treatment of liver cancer by transplantation has evolved into a process of selecting early stage tumors that have a high likelihood of cure. Carefully selected cirrhotic patients with early hepatocellular cancer (≤ 5 cm. diameter and single; ≤ 3 cm. diameter if multiple and 3 or fewer lesions; no vascular invasion) have 5-year actuarial survival rates of approximately 75% after transplantation. Preoperative imaging should be as extensive as necessary to accurately define the characteristics of tumor size, location, and number and exclude signs of extrahepatic involvement. Adjuvant and neoadjuvant chemotherapy became part of treatment protocols in many centers at the same time that more stringent criteria for transplant candidacy were applied to patients with cancer, making it difficult to attribute improved results to the chemotherapy. Nevertheless, neoadjuvant chemoembolization for hepatocellular cancer is logical for patients who may wait long periods before receiving transplants. The fibrolamellar variant of hepatoma is a less aggressive tumor and patients can do well after transplantation, but late recurrences are common. Hepatoblastoma in children can respond very favorably to chemotherapy combined with transplantation.

Cholangiocarcinoma remains a dreadful malignancy. The rare cases of insitu cholangiocarcioma in patients who receive transplants for sclerosing cholangitis can be cured, but known cholangiocarcinoma has an exceedingly high rate of recurrence after transplantation alone. Recent work combining chemotherapy and radiation with transplantation has not had dramatic success at improving cure rates. Patients with metastatic neuroendocrine tumors of the liver can receive good palliation by transplantation, but the majority of patients eventually develop recurrent cancer.

KEYWORD

transplantation - liver - malignancy

REFERENCES

  • 1 Starzl T E, Porter K A, Brettschneider L. Clinical and pathological observations after orthotopic transplantation of the human liver.  Surg Gyn Obstet . 1969;  128 327-339
    PubMedGoogle Scholar
  • 2 Calne R Y, Williams R. Orthotopic liver transplantation: the first 60 patients.  Br Med J. 1977;  1 471-476
    PubMedGoogle Scholar
  • 3 Pichlmayr R, Broelsch C, Wonigeit K. Experiences with liver transplantation in Hanover.  Hepatology . 1984;  4 56S-60S
    PubMedGoogle Scholar
  • 4 Pichlmayr R. Is there a place for liver grafting for malignancy?.  Trans Proc . 1988;  20 478-482
    PubMedGoogle Scholar
  • 5 Mazzaferro V, Regalia E, Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med . 1996;  334 693-699
    CrossrefPubMedGoogle Scholar
  • 6 UNOS 1998 Annual Report. The US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network Richmond, Virginia: Dept of Health and Social Services; 1998
  • 7 Llovet J M, Bruix J, Fuster J. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastases classification does not have prognostic power.  Hepatology . 1998;  27 1572-1577
    CrossrefPubMedGoogle Scholar
  • 8 Penn I. Hepatic transplantation for primary and metastatic cancers of the liver.  Surgery . 1991;  110 726-735
    PubMedGoogle Scholar
  • 9 Iwatsuki S, Klintmalm G BG, Starzl T E. Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy.  World J Surg . 1982;  6 81-85
    CrossrefPubMedGoogle Scholar
  • 10 O'Grady J G, Polson R J, Rolles K. Liver transplantation for malignant disease. Results in 93 consecutive patients.  Ann Surg . 1988;  207 373-379
    PubMedGoogle Scholar
  • 11 Ringe B, Wittekind C, Bechstein W O. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence.  Ann Surg . 1989;  209 88-98
    PubMedGoogle Scholar
  • 12 Bismuth H, Castaing D, Ericzon B FT. Hepatic transplantation in Europe. First report of the European Liver Transplant Registry.  Lancet . 1987;  2 674-676
    PubMedGoogle Scholar
  • 13 Iwatsuki S, Gordon R D, Shaw Jr W B, Starzl T E. Role of liver transplantation in cancer therapy.  Ann Surg . 1985;  202 401-407
    CrossrefPubMedGoogle Scholar
  • 14 Iwatsuki S, Starzl T E, Todo S. Experience in 1000 liver transplants under cyclosporine-steroid therapy: a survival report.  Trans Proc . 1988;  20 498-504
    PubMedGoogle Scholar
  • 15 Oka H, Akihiro T, Kuroki T. Prospective study of afetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.  Hepatology . 1994;  19 61-66
    CrossrefPubMedGoogle Scholar
  • 16 Sherman M, Peltekian K M, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.  Hepatology . 1995;  22 432-438
    CrossrefPubMedGoogle Scholar
  • 17 Kanematsu M, Hoshi H, Yamada T. Small hepatic nodules in cirrhosis: ultrasonographic, CT, and MR imaging findings.  Abdom Imaging . 1999;  24 47-55
    CrossrefPubMedGoogle Scholar
  • 18 Miller W J, Baron R L, Dodd D G, Federle M P. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients.  Radiology . 1994;  193 645-650
    PubMedGoogle Scholar
  • 19 Rizzi P M, Kane P A, Ryder S D. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation.  Gastroenterology . 1994;  107 1425-1429
    PubMedGoogle Scholar
  • 20 Baron R L, Oliver J H, Dodd G D. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.  Radiology . 1996;  199 505-511
    PubMedGoogle Scholar
  • 21 Hirai K, Aoki Y, Majima Y. Magnetic resonance imaging of small hepatocellular carcinoma.  Am J Gastroenterol . 1991;  69 205-209
    PubMedGoogle Scholar
  • 22 Takayasu K, Moriyama N, Muramatsu Y. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients.  Am J Radiol . 1990;  155 49-54
    PubMedGoogle Scholar
  • 23 Spreafico C, Marchiano A, Mazzaferro V. Hepatocellular carcinoma in patients who undergo liver transplantation: sensitivity of CT with iodized oil.  Radiology . 1997;  203 457-460
    PubMedGoogle Scholar
  • 24 VanBeers B, Roche A, Canguil P. Transcatheter arterial chemotherapy using doxorubicin, iodized oil and gelfoam embolization in hepatocellular carcinoma.  Acta Radiologica . 1989;  30 415-418
    PubMedGoogle Scholar
  • 25 Madden M V, Krige J EJ, Bailey S. Randomized trial of targeted chemotherapy with lipoidal and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.  Gut . 1993;  34 1598-1600
    PubMedGoogle Scholar
  • 26 Pelletier G, Roche A, Ink O. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.  Hepatology . 1999;  11 181-184
    PubMedGoogle Scholar
  • 27 Groupe d'etude et de traitment du carcinome hepatocellulaire. A comparison of lipoidal chemoembolization and conservative treatment for unresectible hepatocellular carcinoma.  N Engl J Med . 1995;  332 1256-1261
    CrossrefPubMedGoogle Scholar
  • 28 Harada T, Matsuo K, Inoue T. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?.  Ann Surg . 1996;  224 4-9
    CrossrefPubMedGoogle Scholar
  • 29 Fuster J, Garcia-Valdecasas J C, Grande L. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series.  Annals of Surgery . 1996;  223 297-302
    CrossrefPubMedGoogle Scholar
  • 30 Hermanek P, Sobin L H. TNM Classification of Malignant Tumors.  Berlin: Springer-Verlag 1987: 53-55
    Google Scholar
  • 31 International Union Against Cancer (UICC) TNM classification of malignant tumors. In: Sabin LH, Whittekind CH, eds. New York: Wiley-Liss; 1997: 74-77
    Google Scholar
  • 32 Okuda K, Oltsuki T, Obata H. Natural history of hepatocellular carcinoma and progress in relation to treatment.  Cancer . 1985;  56 918-928
    CrossrefPubMedGoogle Scholar
  • 33 Iwatsuki S, Starzl T E, Sheanan D G. Hepatic resection versus transplantation for hepatocellular carcinoma.  Ann Surg . 1991;  214 221-229
    CrossrefPubMedGoogle Scholar
  • 34 Pichlmayr R, Weimann A, Oldhafer K J. Role of liver transplantation in the treatment of unresectible liver cancer.  World of Surg . 1995;  19 807-813
    CrossrefPubMedGoogle Scholar
  • 35 Klintmalm G. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.  Ann Surg . 1998;  228 479-490
    CrossrefPubMedGoogle Scholar
  • 36 McPeake J R, O'Grady J G, Azman S. Liver Transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome.  Hepatology . 1993;  18 226-234
    CrossrefPubMedGoogle Scholar
  • 37 Figueras J, Juarieta E, Valls C. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.  Hepatology . 1997;  25 1485-1490
    CrossrefPubMedGoogle Scholar
  • 38 Marsh J W, Dvorchik I, Subotin M. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study.  Hepatology . 1997;  26 444-450
    CrossrefPubMedGoogle Scholar
  • 39 Stone M J, Klintmalm G BT, Potter D. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients.  Gastroenterology . 1993;  104 196-202
    PubMedGoogle Scholar
  • 40 Carr B I, Selby R, Madriaga J. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma.  Trans Proc . 1993;  25 1128-1129
    PubMedGoogle Scholar
  • 41 Cherqui D, Piedbois P, Pierga J-Y. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma.  Cancer . 1994;  73 2721-2726
    PubMedGoogle Scholar
  • 42 Olthoff K M, Rosove M H, Shackelton C R. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.  Ann Surg . 1995;  221 734-743
    PubMedGoogle Scholar
  • 43 Koo J, Fung K, Siu K F. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma.  Cancer . 1983;  52 1952-1956
    PubMedGoogle Scholar
  • 44 Yamanaka N, Okamoto E, Fujihara S. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection?.  Cancer . 1992;  70 2263-2267
    PubMedGoogle Scholar
  • 45 Venook A P, Ferrell L D, Roberts J P. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization.  Liver Transpl Surg . 1995;  4 242-248
    PubMedGoogle Scholar
  • 46 Romani F, Belli L S, Rondinara G F. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.  J Amer Coll Surg . 1994;  178 379-384
    PubMedGoogle Scholar
  • 47 Llovet J M, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.  Hepatology . 1999;  30 1434-1440
    CrossrefPubMedGoogle Scholar
  • 48 Majno P E, Adam R, Bismuth. Influence of preoperative transarterial lipoidal chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.  Ann Surg . 1997;  226 688-703
    CrossrefPubMedGoogle Scholar
  • 49 Yokoyama I, Carr B, Saitsu H. Accelerated growth of recurrent hepatocellular carcinoma after liver transplantation.  Cancer . 1991;  68 2095-2100
    PubMedGoogle Scholar
  • 50 Friese C E, Ferrell L, Liu T. Effect of systemic cyclosporine on recurrence after liver transplantation in a model of hepatocellular cancer.  Transplantation . 1999;  67 510-513
    PubMedGoogle Scholar
  • 51 Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients.  World J Surgery . 1991;  15 270-285
    CrossrefPubMedGoogle Scholar
  • 52 Bismuth H, Chiche L, Adam R. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients.  Ann Surg . 1993;  218 145-151
    CrossrefPubMedGoogle Scholar
  • 53 Tan K C, Rela M, Ryder S D. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis.  Brit J Surg . 1995;  82 253-256
    PubMedGoogle Scholar
  • 54 Michel J, Escat J, Fourtanier G. Liver resection or transplantation for hepatocellular carcinoma?.  <~>Retrospective analysis of 215 patients with cirrhosis. Hepatology . 1997;  26 1274-1280
    PubMedGoogle Scholar
  • 55 Otto G, Heuschen J, Hoffman W J. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma.  Ann Surg . 1998;  227 424-432
    CrossrefPubMedGoogle Scholar
  • 56 Belghiti J, Panis Y, Fargeso O. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.  Ann Surg . 1991;  214 114-117
    CrossrefPubMedGoogle Scholar
  • 57 Saxena R, Ye M Q, Emre S. De Novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis.  Liver Transpl Surg . 1999;  5 81-82
    CrossrefPubMedGoogle Scholar
  • 58 Houben K W, McCall J L. Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systemic review.  Liver Trans Surg . 1999;  5 91-95
    PubMedGoogle Scholar
  • 59 Craig J R, Peters R L, Edmonson H A, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathological features.  Cancer . 1980;  46 372-379
    CrossrefPubMedGoogle Scholar
  • 60 Soriede O, Czerniak A, Bradpiece H. Characteristics of fibrolamellar hepatocellular carcinoma.  Amer J Surg . 1986;  151 518-523
    CrossrefPubMedGoogle Scholar
  • 61 Starzl T E, Iwatsuki S, Shaw Jr W B. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver.  Surg Gynaec Obstet . 1986;  162 145-148
    PubMedGoogle Scholar
  • 62 Ringe B, Wittekind C, Weimann A. Results of hepatic resection and transplantation for fibrolamellar carcinoma.  Surg Gynaec Obstet . 1992;  175 299-305
    PubMedGoogle Scholar
  • 63 Pinna A D, Iwatsuki S, Lee R G. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.  Hepatology . 1997;  26 877-883
    CrossrefPubMedGoogle Scholar
  • 64 Ortega J A, Krailo M D, Haas J E. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion Adriamycin chemotherapy: a report from the Children's Cancer Study Group.  J Clin Oncol . 1991;  9 2167-2176
    PubMedGoogle Scholar
  • 65 Seo T, Ando H, Wantanabe Y. Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin.  Surgery . 1998;  123 407-414
    CrossrefPubMedGoogle Scholar
  • 66 Tagge E P, Tagge D U, Reyes J. Resection, including transplantation for hepatoblastoma and hepatocellular carcinoma: impact on survival.  J Paed Surg . 1992;  27 292-297
    PubMedGoogle Scholar
  • 67 Koneru B, Flye M W, Busuttil R W. Liver transplantation for hepatoblastoma. The American experience.  Ann Surg . 1991;  213 118-121
    PubMedGoogle Scholar
  • 68 Marino I R, Todo S, Tzakis A G. Treatment of epitheloid hemangioendothelioma with liver transplantation.  Cancer . 1998;  62 2079-2084
    PubMedGoogle Scholar
  • 69 Casavilla F A, Marsh J W, Iwatsuki S. Hepatic resection and transplantation for peripheral cholangiocarcinoma.  Journal Amer Coll Surgeons . 1997;  185 429-436
    CrossrefPubMedGoogle Scholar
  • 70 Iwatsuki S, Todo S, Marsh J W. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.  J Amer Coll Surgeons . 1998;  187 358-364
    PubMedGoogle Scholar
  • 71 Madariaga J R, Iwatsuki S, Todo S. Liver resection for Hilar and peripheral cholangiocarcinomas: a study of 62 cases.  Ann Surg . 1998;  227 70-79
    CrossrefPubMedGoogle Scholar
  • 72 Goldstein R M, Stone M J, Tillory G W. Is liver transplantation indicated for cholangiocarcinoma?.  Amer J Surg . 1993;  166 768-772
    PubMedGoogle Scholar
  • 73 Urego M, Flickinger J C, Carr B I. Radiotherapy and multimodality management of cholangiocarcinoma.  Int J Radiation Oncol Biol Phys . 1999;  44 121-126
    PubMedGoogle Scholar
  • 74 Neuhaus P, Jonas S, Bechstein W O. Extended resection for hilar cholangiocarcinoma.  Ann Surg . 1999;  230 808-819
    CrossrefPubMedGoogle Scholar
  • 75 Pichlmayr R, Weismann A, Klempnauer J. Surgical treatment in proximal bile duct cancer. A single center experience.  Ann Surg . 1996;  224 628-638
    CrossrefPubMedGoogle Scholar
  • 76 Lindor K D, Wiesner R H, MacCarty R L. Advances in primary sclerosing cholangitis.  Am J Med . 1990;  89 73-80
    CrossrefPubMedGoogle Scholar
  • 77 Broome U, Olsson R, Loof L. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.  Gut . 1996;  38 610-615
    PubMedGoogle Scholar
  • 78 Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.  Scand J Gastroenterology . 1997;  32 1042-1045
    PubMedGoogle Scholar
  • 79 Nichols J C, Gores G L, LaRusso N F. Diagnostic role of serum CA19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis.  Mayo Clin Proc . 1993;  68 874-879
    PubMedGoogle Scholar
  • 80 Ramage J K, Donaghy A, Farrant J M. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.  Gastroenterology . 1995;  108 865-869
    CrossrefPubMedGoogle Scholar
  • 81 Fisher A, Theise N D, Min A. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.  Liver Transpl Surg . 1995;  1 94-98
    PubMedGoogle Scholar
  • 82 Hultcrantz R, Olsson R, Danielsson A. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.  J Hepatology . 1999;  30 669-673
    CrossrefPubMedGoogle Scholar
  • 83 Bjornsson E, Kilander A, Olsson R. CA19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis.  Liver . 1999;  19 501-508
    PubMedGoogle Scholar
  • 84 Goss J A, Shackleton C R, Farmer D G. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.  Ann Surg . 1997;  225 472-483
    CrossrefPubMedGoogle Scholar
  • 85 Delcore R, Friesen S R. Gastrointestinal neuroendocrine tumors.  J Amer Coll Surg . 1994;  178 188-211
    PubMedGoogle Scholar
  • 86 Norheim I, Oberg K, Theodorsson-Norheim E. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production and survival.  Ann Surg . 1987;  206 115-125
    PubMedGoogle Scholar
  • 87 Makowka l, Tzakis A G, Mazzaferro V. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas.  Surg Gyn & Ostet . 1989;  168 107-111
    PubMedGoogle Scholar
  • 88 Routley D, Ramage J K, McPeake J. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver.  Liver Transpl Surg . 1995;  1 118-121
    PubMedGoogle Scholar
  • 89 Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma. An analysis of 103 patients.  Transplantation . 1998;  66 1307-1312
    CrossrefPubMedGoogle Scholar
  • 90 Dousset B, Houssin D, Soubrane O. Metastatic endocrine tumors: is there a place for liver transplantation.  Liver Transpl Surg . 1995;  1 111-117
    PubMedGoogle Scholar
  • 91 LeTreut Y P, Delpero J R, Dousset B. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors.  Ann Surg . 1997;  225 355-362
    CrossrefPubMedGoogle Scholar
  • 92 Lang H, Oldhafer K J, Weimann A. Liver transplantation for metastatic neuroendocrine tumors.  Ann Surg . 1997;  225 347-354
    CrossrefPubMedGoogle Scholar
  • 93 Anthuber M, Karl-Walter J, Briegel J. Results of liver transplantation for gastropancreatic tumor metastases.  World J Surg . 1996;  20 73-76
    CrossrefPubMedGoogle Scholar
  • 94 Arnold J C, O'Grady J G, Bird G L. Liver transplantation for primary and secondary hepatic apudomas.  Brit J Surg . 1989;  78 248-249
    PubMedGoogle Scholar
  • 95 Knechtle S J, Kalayoglu M, D'Alessandro A M. Should abdominal cluster transplantation be abandoned?.  Trans Proc . 1993;  25 1361-1363
    PubMedGoogle Scholar
      >